USX:AMLX - Amylyx Pharmaceuticals Inc Amylyx Pharmaceuticals Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 8 Aug 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 1.83    -0.02 (-1.08%)

26 Jun 2024


Loading...
Loading...
Loading...

General

CEO: Mr. Joshua B. Cohen

IPO: 2022-01-07

Headquarters: US

Employees: 384

Homepage

Description

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T4

About · FAQs · StocksCafe © 2024 · Privacy · Terms